Clinical Trial Update: CCI-779 in Treating Patients With Advanced Solid Tumors [Phase 1]

View source ↗

Summary

Phase 1 trial of CCI-779 (temsirolimus) in patients with advanced solid tumors, including brain/CNS tumors and metastatic cancer, has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Cancer
• Cancer
• Unspecified Adult Solid Tumor

Drugs mentioned

• Torisel (Temsirolimus)

Snippet

Sponsor: The University of Texas Health Science Center at San Antonio | Conditions: Brain and Central Nervous System Tumors, Metastatic Cancer | Phase 1 | Status: COMPLETED